Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.
Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ; Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Mandelblatt JS, et al. Among authors: van ravesteyn nt. Ann Intern Med. 2009 Nov 17;151(10):738-47. doi: 10.7326/0003-4819-151-10-200911170-00010. Ann Intern Med. 2009. PMID: 19920274 Free PMC article.
Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States.
van Ravesteyn NT, Schechter CB, Near AM, Heijnsdijk EA, Stoto MA, Draisma G, de Koning HJ, Mandelblatt JS. van Ravesteyn NT, et al. Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):112-22. doi: 10.1158/1055-9965.EPI-10-0944. Epub 2010 Nov 30. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21119071 Free PMC article.
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ. van Ravesteyn NT, et al. Ann Intern Med. 2012 May 1;156(9):609-17. doi: 10.7326/0003-4819-156-9-201205010-00002. Ann Intern Med. 2012. PMID: 22547470 Free PMC article.
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.
Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, van Ravesteyn NT, Tosteson AN, Mandelblatt JS. Stout NK, et al. Among authors: van ravesteyn nt. J Natl Cancer Inst. 2014 May 28;106(6):dju092. doi: 10.1093/jnci/dju092. Print 2014 Jun. J Natl Cancer Inst. 2014. PMID: 24872543 Free PMC article.
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.
Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EA, Pabiniak C, van Ballegooijen M, Rutter CM, Kuntz KM, Feuer EJ, Etzioni R, de Koning HJ, Zauber AG, Mandelblatt JS. Lansdorp-Vogelaar I, et al. Among authors: van ravesteyn nt, van ballegooijen m. Ann Intern Med. 2014 Jul 15;161(2):104-12. doi: 10.7326/M13-2867. Ann Intern Med. 2014. PMID: 25023249 Free PMC article.
77 results